Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 59343
                    [Title] => IPI: Widespread production affects VCO validity abroad
                    [Summary] => 
            
                    [DatePublished] => 2008-05-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1298072
                    [AuthorName] => Ehda Dagooc
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 58107
                    [Title] => IPI boosts market presence overseas
                    [Summary] => 
            
Cebuano-owned International Pharmaceuticals Inc. (IPI) is strengthening its presence in the overseas market, specifically hitting the G8 countries like United States and the European Union (EU).
                    [DatePublished] => 2008-04-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1298072
                    [AuthorName] => Ehda Dagooc
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

        )

)

GALVELO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 59343
                    [Title] => IPI: Widespread production affects VCO validity abroad
                    [Summary] => 
            
                    [DatePublished] => 2008-05-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1298072
                    [AuthorName] => Ehda Dagooc
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 58107
                    [Title] => IPI boosts market presence overseas
                    [Summary] => 
            
Cebuano-owned International Pharmaceuticals Inc. (IPI) is strengthening its presence in the overseas market, specifically hitting the G8 countries like United States and the European Union (EU).
                    [DatePublished] => 2008-04-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1298072
                    [AuthorName] => Ehda Dagooc
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

        )

)

abtest

IPI: Widespread production affects VCO validity abroad

By Ehda Dagooc | May 1, 2008 - 12:00am

Freeman Cebu Business

IPI boosts market presence overseas

By Ehda Dagooc | April 25, 2008 - 12:00am

Cebuano-owned International Pharmaceuticals Inc. (IPI) is strengthening its presence in the overseas market, specifically hitting the G8 countries like United States and the European Union (EU).

Freeman Cebu Business